-
Location
-
400 Technology Square, 10 Th Floor, Cambridge, MA
-
Summary
-
The estimated value of insider holdings of Atlas Venture Fund XI, L.P. is at least $389M dollars as of February 10, 2025. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Dyne Therapeutics, Inc. and owns shares of Dyne Therapeutics, Inc. (DYN) stock worth about $166M. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Third Harmonic Bio, Inc. and owns shares of Third Harmonic Bio, Inc. (THRD) stock worth about $140M. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Day One Biopharmaceuticals, Inc. and owns shares of Day One Biopharmaceuticals, Inc. (DAWN) stock worth about $70.2M. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Ikena Oncology, Inc. and owns shares of Ikena Oncology, Inc. (IKNA) stock worth about $11.4M. Atlas Venture Fund XI, L.P. is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $1.76M.
-
Signature
-
Atlas Venture Fund XI, L.P., By: Atlas Venture Associates XI, L.P., its general partner, by Atlas Venture Associates XI, LLC, its general partner, By: /s/ Ommer Chohan, Chief Financial Officer